PSG12- HOSPITAL COST SAVINGS FROM SEVERITY-ADJUSTED LENGTH OF STAY FOLLOWING SURGERY FOR INTRA-ABDOMINAL INFECTION AND TREATMENT WITH PIPERACILLIN/ TAZOBACTAM OR IMIPENEM/CILASTATIN
Mar 1, 2000, 00:00 AM
10.1016/S1098-3015(11)70579-4
https://www.valueinhealthjournal.com/article/S1098-3015(11)70579-4/fulltext
Section Title :
Section Order :
131
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70579-4&doi=10.1016/S1098-3015(11)70579-4